Your browser doesn't support javascript.
loading
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer.
Martínez-Cardús, Anna; Moran, Sebastian; Musulen, Eva; Moutinho, Cátia; Manzano, Jose L; Martinez-Balibrea, Eva; Tierno, Montserrat; Élez, Elena; Landolfi, Stefania; Lorden, Patricia; Arribas, Carles; Müller, Fabian; Bock, Christoph; Tabernero, Josep; Esteller, Manel.
Afiliación
  • Martínez-Cardús A; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
  • Moran S; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
  • Musulen E; Pathology Department, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain.
  • Moutinho C; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
  • Manzano JL; Medical Oncology Department, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain.
  • Martinez-Balibrea E; Catalan Institute of Oncology, Health Sciences Research Institute of the Germans Trias i Pujol Foundation, Barcelona, Catalonia, Spain.
  • Tierno M; Catalan Institute of Oncology, Health Sciences Research Institute of the Germans Trias i Pujol Foundation, Barcelona, Catalonia, Spain.
  • Élez E; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Center affiliated with the Spanish Cancer Research Network (Institute of Health Carlos III), Spain.
  • Landolfi S; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Catalonia, Spain.
  • Lorden P; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
  • Arribas C; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
  • Müller F; Max Planck Institute for Informatics, Saarbrücken, Germany.
  • Bock C; Max Planck Institute for Informatics, Saarbrücken, Germany; Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.
  • Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Center affiliated with the Spanish Cancer Research Network (Institute of Health Carlos III), Spain.
  • Esteller M; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain; Institucio Catalana de Recerca i Estudis Avançats, Barcelona,
Gastroenterology ; 151(5): 961-972, 2016 11.
Article en En | MEDLINE | ID: mdl-27521480

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Metilación de ADN / Epigénesis Genética Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Año: 2016 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Metilación de ADN / Epigénesis Genética Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Año: 2016 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos